Does Diabetic Microvascular Complications Affect Gastrointestinal Symptoms?

  • Akram Ghadiri Anari Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Somayeh Gholami Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Elham Sheyda Department of Internal Medicine, Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Shadab Kharazmi Department of General Psychology, Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Nasim Namiranian Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Keywords: Type 2 diabetes mellitus, Gastrointestinal symptom, Diabetic nephropathy, Diabetic retinopathy

Abstract

Due to high prevalence of diabetes in our region (16.3%) and no data on the frequency of gastrointestinal (GI) symptoms in this population, we performed a cross-sectional study to evaluate the frequency of GIsymptoms in diabetic patients and its association between microvascular complications (retinopathy and nephropathy) and gastrointestinal symptoms in diabetic subjects.This analytical cross-sectional study was conducted from 2014 to 2016 on 233 patients with type 2 diabetes mellitus (T2DM), 30-65-year, referred to Yazd diabetic research center. They were selected by convenient sample method. A questionnaire according to Rome III Criteria was used to collect digestive information related to diabetes. Last HbA1c (Since 2-3 months ago) was available in the patient's medical folder. Diabetic nephropathy defines to increased excretion rate of albumin in the urine in the range of above 30 mg/g creatinine. Diabetic retinopathy was examined by an expert ophthalmologist (retinal specialist). For the current study, 233 patients (age 30-65 years with mean age of 57.43±10.49 years, 102 (43.8%) males and 131 (56.2%) females) were included. Among 233 patients, 91 cases (39.1%) had nephropathy,and 111(47.6%) subjects had different degrees of retinopathy. Bloating and early satiety and upper GI symptoms were higher in the subjects with retinopathy than another group. In summary, this study provides evidence that GI symptoms in diabetic subjects are independently linked to diabetic complications, particularly to retinopathy.

References

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes research and clinical practice. 2010;87(1):4-14.

Fowler MJ. Microvascular and macrovascular complications of diabetes.Clinical diabetes. 2008;26(2):77-82.

Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circulation research. 2010 Oct 29;107(9):1058-70.

Krishnan B, Babu S, Walker J, Walker AB, Pappachan JM. Gastrointestinal complications of diabetes mellitus.World journal of diabetes. 2013;4(3):51.

Choi KM, Gibbons SJ, Nguyen TV, et al. Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology. 2008; 135:2055–64.

Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut. 2010; 59:1716–26.

Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15 000 adults. Archives of Internal Medicine. 2001 Sep 10;161(16):1989-96.

Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. The American journal of gastroenterology. 2002;97(3):604-11.

Hyett B, Martinez FJ, Gill BM, Mehra S, Lembo A, Kelly CP, Leffler DA. Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology. 2009 Aug 31;137(2):445-52.

Gustafsson RJ, Littorin B, Berntorp K, Frid A, Thorsson O, Olsson R, Ekberg O, Ohlsson B. Esophageal dysmotility is more common than gastroparesis in diabetes mellitus and is associated with retinopathy. The review of diabetic studies: RDS. 2011;8(2):268.

Lotfi MH, Saadati H, Afzali M. Prevalence of diabetes in people aged≥ 30 years: the results of screen-ing program of Yazd Province, Iran, in 2012. Journal of research in health sciences. 2013 May 8;14(1):88-92.

Drossman DA, Dumitrascu DL. Rome III: New standard for functional gastrointestinal disorders. Journal of Gastrointestinal and Liver Diseases. 2006;15(3):237.

Toto RD. Microalbuminuria: definition, detection, and clinical significance. The journal of clinical hypertension. 2004;6(s11):2-7.

Demedts I, Masaoka T, Kindt S, De Hertogh G, Geboes K, Farré R, Berghe PV, Tack J. Gastrointestinal motility changes and myenteric plexus alterations in spontaneously diabetic biobreeding rats. Journal of neurogastroenterology and motility. 2013;19(2):161.

Fosnes GS, Lydersen S, Farup PG. Constipation and diarrhoea – common adverse drug reactions? A cross sectional study in the general population. BMC Clin Pharmacol. 2011;11:2.

Kim JH, Park HS, Ko SY, Hong SN, Sung IK, Shim CS, Song KH, Kim DL, Kim SK, Oh J. Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes. World Journal of Gastroenterology: WJG. 2010;16(14):1782.

Kilpatrick ES. Glycated haemoglobin in the year 2000. J Clin Pathol. 2000;53(5):335–339.

Published
2019-05-13
How to Cite
1.
Ghadiri Anari A, Gholami S, Sheyda E, Kharazmi S, Namiranian N. Does Diabetic Microvascular Complications Affect Gastrointestinal Symptoms?. Acta Med Iran. 57(3):156-159.
Section
Articles